Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Ted Skolarus

TitleProfessor
InstitutionUniversity of Chicago
DepartmentSurgery-Urology
AddressChicago IL 60637
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Stensland KD, Damschroder LJ, Sales AE, Schott AF, Skolarus TA. Envisioning clinical trials as complex interventions. Cancer. 2022 09 01; 128(17):3145-3151. PMID: 35766902.
      View in: PubMed
    2. Radhakrishnan A, Wallner LP, Skolarus TA, George AK, Rosenberg BH, Abrahamse P, Hawley ST. Exploring Variation in the Receipt of Recommended Active Surveillance for Men with Favorable-Risk Prostate Cancer. J Urol. 2022 09; 208(3):600-608. PMID: 35522191.
      View in: PubMed
    3. Stensland KD, Devasia T, Caram MEV, Chapman C, Zaslavsky A, Morgan TM, Hollenbeck BK, Sparks JB, Burns J, Vedapudi V, Duchesne GM, Tsodikov A, Skolarus TA. Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy. JNCI Cancer Spectr. 2022 05 02; 6(3). PMID: 35616109.
      View in: PubMed
    4. Singhal U, Skolarus TA, Gore JL, Parry MG, Chen RC, Nossiter J, Paniagua-Cruz A, George AK, Cathcart P, Meulen JV, Wittmann DA. Implementation of patient-reported outcome measures into health care for men with localized prostate cancer. Nat Rev Urol. 2022 05; 19(5):263-279. PMID: 35260844.
      View in: PubMed
    5. Parry MG, Nossiter J, Morris M, Sujenthiran A, Skolarus TA, Berry B, Nathan A, Cathcart P, Aggarwal A, van der Meulen J, Trinh QD, Payne H, Clarke NW. Comparison of the treatment of men with prostate cancer between the US and England: an international population-based study. Prostate Cancer Prostatic Dis. 2022 Jan 10. PMID: 35001083.
      View in: PubMed
    6. Parry MG, Skolarus TA, Nossiter J, Sujenthiran A, Morris M, Cowling TE, Berry B, Aggarwal A, Payne H, Cathcart P, Clarke NW, van der Meulen J. Urinary incontinence and use of incontinence surgery after radical prostatectomy: a national study using patient-reported outcomes. BJU Int. 2022 07; 130(1):84-91. PMID: 34846770.
      View in: PubMed
    7. Wittmann D, Mehta A, Bober SL, Zhu Z, Daignault-Newton S, Dunn RL, Braun TM, Carter C, Duby A, Northouse LL, Koontz BF, Glodé LM, Brandon J, Bangs R, McPhail J, McPhail S, Arab L, Paich K, Skolarus TA, An LC, Nelson CJ, Saigal CS, Chen RC, Mulhall JP, Hawley ST, Hearn JWD, Spratt DE, Pollack CE. TrueNTH Sexual Recovery Intervention for couples coping with prostate cancer: Randomized controlled trial results. Cancer. 2022 Apr 01; 128(7):1513-1522. PMID: 34985771.
      View in: PubMed
    8. Wittmann D, Varlamos C, Rodriguez-Galano N, Day L, Grube G, Shifferd J, Erickson K, Duby A, Morgan TM, Hollenbeck BK, Skolarus TA, Salami SS, Kaffenberger SD, Montie JE. Developing a Patient-Centered Model of Prostate Cancer Care: Patient Satisfaction With a Survivorship Program Embedded in Urologic-Oncologic Care. Urology. 2022 02; 160:161-167. PMID: 34896123.
      View in: PubMed
    9. Lai LY, Oerline MK, Kaufman SR, Herrel LA, Skolarus TA, Dusetzina SB, Ellimoottil C, Shahinian VB, Hollenbeck BK, Caram MEV. Promotional Payments to Medical Oncologists and Urologists and Prescriptions for Abiraterone and Enzalutamide. Urology. 2022 Mar; 161:50-58. PMID: 34861316.
      View in: PubMed
    10. Skolarus TA, Forman J, Sparks JB, Metreger T, Hawley ST, Caram MV, Dossett L, Paniagua-Cruz A, Makarov DV, Leppert JT, Shelton JB, Stensland KD, Hollenbeck BK, Shahinian V, Sales AE, Wittmann DA. Learning from the "tail end" of de-implementation: the case of chemical castration for localized prostate cancer. Implement Sci Commun. 2021 Oct 28; 2(1):124. PMID: 34711274.
      View in: PubMed
    11. MacLennan S, Duncan E, Skolarus TA, Roobol MJ, Kasivisvanathan V, Gallagher K, Gandaglia G, Sakalis V, Smith EJ, Plass K, Ribal MJ, N'Dow J, Briganti A. Improving Guideline Adherence in Urology. Eur Urol Focus. 2022 Sep; 8(5):1545-1552. PMID: 34702647.
      View in: PubMed
    12. Stensland KD, Kaffenberger SD, George AK, Morgan TM, Miller DC, Salami SS, Dunn RL, Palapattu GS, Montgomery JS, Hollenbeck BK, Skolarus TA. Prostate cancer clinical trial completion: The role of geography. Contemp Clin Trials. 2021 12; 111:106600. PMID: 34673273.
      View in: PubMed
    13. Soerensen SJC, Thomas IC, Schmidt B, Daskivich TJ, Skolarus TA, Jackson C, Osborne TF, Chertow GM, Brooks JD, Rehkopf DH, Leppert JT. AUTHOR REPLY. Urology. 2021 09; 155:76. PMID: 34489006.
      View in: PubMed
    14. Stensland KD, Daignault-Newton S, Skolarus TA. Considerations in the Analysis of Clinical Trial Failure. J Urol. 2022 01; 207(1):9-11. PMID: 34448630.
      View in: PubMed
    15. Stensland KD, Daignault-Newton S, Skolarus TA. Designing lean, efficient clinical trials is an ethical imperative: the fragility index should not be used in the design of randomized clinical trials. Urol Oncol. 2021 10; 39(10):738-739. PMID: 34400067.
      View in: PubMed
    16. Stensland KD, Skolarus TA. EDITORIAL COMMENT. Urology. 2021 07; 153:145-146. PMID: 34311908.
      View in: PubMed
    17. Soerensen SJC, Thomas IC, Schmidt B, Daskivich TJ, Skolarus TA, Jackson C, Osborne TF, Chertow GM, Brooks JD, Rehkopf DH, Leppert JT. Using an Automated Electronic Health Record Score To Estimate Life Expectancy In Men Diagnosed With Prostate Cancer In The Veterans Health Administration. Urology. 2021 09; 155:70-76. PMID: 34139251.
      View in: PubMed
    18. Lamb BW, Miah S, Skolarus TA, Stewart GD, Green JSA, Sevdalis N, Soukup T. Development and Validation of a Short Version of the Metric for the Observation of Decision-Making in Multidisciplinary Tumor Boards: MODe-Lite. Ann Surg Oncol. 2021 Nov; 28(12):7577-7588. PMID: 33974197.
      View in: PubMed
    19. Lai LY, Shahinian VB, Oerline MK, Kaufman SR, Skolarus TA, Caram MEV, Hollenbeck BK. Understanding Active Surveillance for Prostate Cancer. JCO Oncol Pract. 2021 11; 17(11):e1678-e1687. PMID: 33830822.
      View in: PubMed
    20. Wang T, Bredbeck BC, Sinco B, Shubeck S, Baskin AS, Skolarus T, Dossett LA. Variations in Persistent Use of Low-Value Breast Cancer Surgery. JAMA Surg. 2021 04 01; 156(4):353-362. PMID: 33533894.
      View in: PubMed
    21. Caram MEV, Burns J, Kumbier K, Sparks JB, Tsao PA, Chapman CH, Bauman J, Hollenbeck BK, Shahinian VB, Skolarus TA. Factors influencing treatment of veterans with advanced prostate cancer. Cancer. 2021 07 01; 127(13):2311-2318. PMID: 33764537.
      View in: PubMed
    22. Soukup T, Sevdalis N, Green JSA, Lamb BW, Chapman C, Skolarus TA. Making Tumor Boards More Patient-Centered: Let's Start With the Name. JCO Oncol Pract. 2021 10; 17(10):591-593. PMID: 33734827.
      View in: PubMed
    23. Marchetti KA, Oerline M, Hollenbeck BK, Kaufman SR, Skolarus TA, Shahinian VB, Caram MEV, Modi PK. Urology Workforce Changes and Implications for Prostate Cancer Care Among Medicare Enrollees. Urology. 2021 09; 155:77-82. PMID: 33610652.
      View in: PubMed
    24. Stensland KD, DePorto K, Ryan J, Kaffenberger S, Reinstatler LS, Galsky M, Canes D, Skolarus TA, Moinzadeh A. Estimating the rate and reasons of clinical trial failure in urologic oncology. Urol Oncol. 2021 03; 39(3):154-160. PMID: 33257221.
      View in: PubMed
    25. Radhakrishnan A, Wallner LP, Skolarus TA, Abrahamse PH, Kollipara AS, Katz SJ, Hawley ST. Primary Care Providers' Perceptions About Participating in Low-Risk Prostate Cancer Treatment Decisions. J Gen Intern Med. 2021 02; 36(2):447-454. PMID: 33123958.
      View in: PubMed
    26. Cruz AP, Skolarus TA, Ambani SN, Hafez K, Kraft KH. Aligning Urology Residency Training With Real-World Workforce Needs. J Surg Educ. 2021 May-Jun; 78(3):820-827. PMID: 33046414.
      View in: PubMed
    27. Berlin NL, Dimick JB, Kerr EA, Skolarus TA, Dossett LA. Demand for Surgical Procedures Following COVID-19: The Need for Operational Strategies That Optimize Resource Utilization and Value. Ann Surg. 2020 10; 272(4):e272-e274. PMID: 32932326.
      View in: PubMed
    28. Wittmann D, Skolarus T, Glodé LM. Reconsidering the Trade-offs of Prostate Cancer Screening. N Engl J Med. 2020 09 24; 383(13):1289-1290. PMID: 32966735.
      View in: PubMed
    29. Caram MEV, Oerline MK, Dusetzina S, Herrel LA, Modi PK, Kaufman SR, Skolarus TA, Hollenbeck BK, Shahinian V. Adherence and out-of-pocket costs among Medicare beneficiaries who are prescribed oral targeted therapies for advanced prostate cancer. Cancer. 2020 12 01; 126(23):5050-5059. PMID: 32926427.
      View in: PubMed
    30. Wallis CJD, Catto JWF, Finelli A, Glaser AW, Gore JL, Loeb S, Morgan TM, Morgans AK, Mottet N, Neal R, O'Brien T, Odisho AY, Powles T, Skolarus TA, Smith AB, Szabados B, Klaassen Z, Spratt DE. The Impact of the COVID-19 Pandemic on Genitourinary Cancer Care: Re-envisioning the Future. Eur Urol. 2020 11; 78(5):731-742. PMID: 32893062.
      View in: PubMed
    31. Modi PK, Yan P, Hollenbeck BK, Kaufman SR, Borza T, Skolarus TA, Schroeck FR, Ryan AM, Shahinian VB, Herrel LA. Urologist practice structure and quality of prostate cancer care. Urol Pract. 2020 Sep; 7(5):419-424. PMID: 34541260.
      View in: PubMed
    32. Baskin AS, Wang T, Berlin NL, Skolarus TA, Dossett LA. Scope and Characteristics of Choosing Wisely in Cancer Care Recommendations by Professional Societies. JAMA Oncol. 2020 09 01; 6(9):1463-1465. PMID: 32701128.
      View in: PubMed
    33. Kaye DR, Schafer C, Thelen-Perry S, Parker C, Iglay-Reger H, Daignault-Newton S, Qin Y, Morgan TM, Weizer AZ, Kaffenberger SD, Herrel LA, Hafez KS, Lee CT, Skolarus TA, Englesbe MJ, Montgomery JS. The Feasibility and Impact of a Presurgical Exercise Intervention Program (Prehabilitation) for Patients Undergoing Cystectomy for Bladder Cancer. Urology. 2020 11; 145:106-112. PMID: 32739310.
      View in: PubMed
    34. Sohlberg EM, Thomas IC, Yang J, Kapphahn K, Daskivich TJ, Skolarus TA, Shelton JB, Makarov DV, Bergman J, Bang CK, Goldstein MK, Wagner TH, Brooks JD, Desai M, Leppert JT. Life expectancy estimates for patients diagnosed with prostate cancer in the Veterans Health Administration. Urol Oncol. 2020 09; 38(9):734.e1-734.e10. PMID: 32674954.
      View in: PubMed
    35. Stensland K, Kaffenberger S, Canes D, Galsky M, Skolarus T, Moinzadeh A. Assessing Genitourinary Cancer Clinical Trial Accrual Sufficiency Using Archived Trial Data. JCO Clin Cancer Inform. 2020 07; 4:614-622. PMID: 32667822.
      View in: PubMed
    36. Urish KL, Qin Y, Salka B, Li BY, Borza T, Sessine M, Kirk P, Hollenbeck BK, Helm JE, Lavieri MS, Skolarus TA, Jacobs BL. Comparison of readmission and early revision rates as a quality metric in total knee arthroplasty using the Nationwide Readmission Database. Ann Transl Med. 2020 Jun; 8(11):687. PMID: 32617307.
      View in: PubMed
    37. Berlin NL, Skolarus TA, Kerr EA, Dossett LA. Too Much Surgery: Overcoming Barriers to Deimplementation of Low-value Surgery. Ann Surg. 2020 06; 271(6):1020-1022. PMID: 32209904.
      View in: PubMed
    38. Soukup T, Morbi A, Lamb BW, Gandamihardja TAK, Hogben K, Noyes K, Skolarus TA, Darzi A, Sevdalis N, Green JSA. A measure of case complexity for streamlining workflow in multidisciplinary tumor boards: Mixed methods development and early validation of the MeDiC tool. Cancer Med. 2020 07; 9(14):5143-5154. PMID: 32476281.
      View in: PubMed
    39. Sessine MS, Weizer A, Kirk PS, Borza T, Jacobs BL, Qin Y, Oerline M, Li B, Modi PK, Lavieri MS, Gilbert SM, Montgomery JS, Hollenbeck BK, Urish K, Helm JE, Skolarus TA. Reframing Financial Incentives Around Reducing Readmission After Radical Cystectomy. Urology. 2020 08; 142:99-105. PMID: 32413517.
      View in: PubMed
    40. Kirk PS, Liu X, Borza T, Li BY, Sessine M, Zhu K, Lesse O, Qin Y, Jacobs B, Urish K, Helm J, Gilbert S, Weizer A, Montgomery J, Hollenbeck BK, Lavieri M, Skolarus TA. Dynamic readmission prediction using routine postoperative laboratory results after radical cystectomy. Urol Oncol. 2020 04; 38(4):255-261. PMID: 31953004.
      View in: PubMed
    41. Hugar LA, Borza T, Oerline MK, Hollenbeck BK, Skolarus TA, Jacobs BL. Resurrecting immortal-time bias in the study of readmissions. Health Serv Res. 2020 04; 55(2):273-276. PMID: 31880314.
      View in: PubMed
    42. Macleod LC, Fam MM, Yabes JG, Hale NE, Turner RM, Lopa SH, Gingrich JR, Borza T, Skolarus TA, Davies BJ, Jacobs BL. Comparison of Neoadjuvant and Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer. Clin Genitourin Cancer. 2020 06; 18(3):201-209.e2. PMID: 31917172.
      View in: PubMed
    43. Skolarus TA, Dauw CA, Fowler KE, Mann JD, Bernstein SJ, Meddings J. Catheter management after benign transurethral prostate surgery: RAND/UCLA Appropriateness Criteria. Am J Manag Care. 2019 12 01; 25(12):e366-e372. PMID: 31860230.
      View in: PubMed
    44. Paniagua Cruz A, Zhu KY, Ellimoottil C, Dauw CA, Sarma A, Skolarus TA. Characterizing the Benign Prostatic Hyperplasia Literature: A Bibliometric Analysis. Urology. 2020 Feb; 136:202-211. PMID: 31801683.
      View in: PubMed
    45. Chapman CH, Caram MEV, Radhakrishnan A, Tsodikov A, Deville C, Burns J, Zaslavsky A, Chang M, Leppert JT, Hofer T, Sales AE, Hawley ST, Hollenbeck BK, Skolarus TA. Association between PSA values and surveillance quality after prostate cancer surgery. Cancer Med. 2019 12; 8(18):7903-7912. PMID: 31691526.
      View in: PubMed
    46. Li BY, Urish KL, Jacobs BL, He C, Borza T, Qin Y, Min HS, Dupree JM, Ellimoottil C, Hollenbeck BK, Lavieri MS, Helm JE, Skolarus TA. Inaugural Readmission Penalties for Total Hip and Total Knee Arthroplasty Procedures Under the Hospital Readmissions Reduction Program. JAMA Netw Open. 2019 11 01; 2(11):e1916008. PMID: 31755949.
      View in: PubMed
    47. Daskivich TJ, Thomas IC, Luu M, Shelton JB, Makarov DV, Skolarus TA, Leppert JT. Reply by Authors. J Urol. 2020 02; 203(2):421. PMID: 31596670.
      View in: PubMed
    48. Modi PK, Kaufman SR, Herrel LA, Dupree JM, Luckenbaugh AN, Skolarus TA, Hollenbeck BK, Shahinian VB. Practice-Level Adoption of Conservative Management for Prostate Cancer. J Oncol Pract. 2019 10; 15(10):e863-e869. PMID: 31509481.
      View in: PubMed
    49. Hale NE, Macleod LC, Yabes JG, Turner RM, Fam MM, Gingrich JR, Skolarus TA, Borza T, Sabik LM, Davies BJ, Jacobs BL. Implications of Cystectomy Travel Distance for Hospital Readmission and Survival. Clin Genitourin Cancer. 2019 12; 17(6):e1171-e1180. PMID: 31543443.
      View in: PubMed
    50. Kirk PS, Skolarus TA, Jacobs BL, Qin Y, Li B, Sessine M, Liu X, Zhu K, Gilbert SM, Hollenbeck BK, Urish K, Helm J, Lavieri MS, Borza T. Characterising 'bounce-back' readmissions after radical cystectomy. BJU Int. 2019 12; 124(6):955-961. PMID: 31313473.
      View in: PubMed
    51. Daskivich TJ, Thomas IC, Luu M, Shelton JB, Makarov DV, Skolarus TA, Leppert JT. External Validation of the Prostate Cancer Specific Comorbidity Index: A Claims Based Tool for the Prediction of Life Expectancy in Men with Prostate Cancer. J Urol. 2019 09; 202(3):518-524. PMID: 31009286.
      View in: PubMed
    52. Caram MEV, Kaufman SR, Modi PK, Herrel L, Oerline M, Ross R, Skolarus TA, Hollenbeck BK, Shahinian V. Adoption of Abiraterone and Enzalutamide by Urologists. Urology. 2019 09; 131:176-183. PMID: 31136769.
      View in: PubMed
    53. Borza T, Oerline MK, Skolarus TA, Norton EC, Dimick JB, Jacobs BL, Herrel LA, Ellimoottil C, Hollingsworth JM, Ryan AM, Miller DC, Shahinian VB, Hollenbeck BK. Association Between Hospital Participation in Medicare Shared Savings Program Accountable Care Organizations and Readmission Following Major Surgery. Ann Surg. 2019 05; 269(5):873-878. PMID: 29557880.
      View in: PubMed
    54. Macleod LC, Yabes JG, Yu M, Fam MM, Hale NE, Turner RM, Lopa SH, Gingrich JR, Borza T, Skolarus TA, Davies BJ, Jacobs BL. Trends and appropriateness of perioperative chemotherapy for muscle-invasive bladder cancer. Urol Oncol. 2019 07; 37(7):462-469. PMID: 31053530.
      View in: PubMed
    55. Modi PK, Herrel LA, Kaufman SR, Yan P, Borza T, Skolarus TA, Schroeck FR, Hollenbeck BK, Shahinian VB. Urologist Practice Structure and Spending for Prostate Cancer Care. Urology. 2019 Aug; 130:65-71. PMID: 31029672.
      View in: PubMed
    56. Radhakrishnan A, Henry J, Zhu K, Hawley ST, Hollenbeck BK, Hofer T, Wittmann DA, Sales AE, Skolarus TA. Determinants of quality prostate cancer survivorship care across the primary and specialty care interface: Lessons from the Veterans Health Administration. Cancer Med. 2019 05; 8(5):2686-2702. PMID: 30950216.
      View in: PubMed
    57. Skolarus TA, Metreger T, Wittmann D, Hwang S, Kim HM, Grubb RL, Gingrich JR, Zhu H, Piette JD, Hawley ST. Self-Management in Long-Term Prostate Cancer Survivors: A Randomized, Controlled Trial. J Clin Oncol. 2019 05 20; 37(15):1326-1335. PMID: 30925126.
      View in: PubMed
    58. Chapman CH, Burns JA, Skolarus TA. Prostate Cancer Surveillance After Radiation Therapy in a National Delivery System. Fed Pract. 2019 Feb; 36(Suppl 1):S16-S21. PMID: 30867631.
      View in: PubMed
    59. Skolarus TA, Hawley ST, Wittmann DA, Forman J, Metreger T, Sparks JB, Zhu K, Caram MEV, Hollenbeck BK, Makarov DV, Leppert JT, Shelton JB, Shahinian V, Srinivasaraghavan S, Sales AE. De-implementation of low value castration for men with prostate cancer: protocol for a theory-based, mixed methods approach to minimizing low value androgen deprivation therapy (DeADT). Implement Sci. 2018 11 29; 13(1):144. PMID: 30486836.
      View in: PubMed
    60. Kirk PS, Borza T, Caram MEV, Shumway DA, Makarov DV, Burns JA, Shelton JB, Leppert JT, Chapman C, Chang M, Hollenbeck BK, Skolarus TA. Characterising potential bone scan overuse amongst men treated with radical prostatectomy. BJU Int. 2019 07; 124(1):55-61. PMID: 30246937.
      View in: PubMed
    61. Agochukwu NQ, Skolarus TA, Wittmann D. Telemedicine and prostate cancer survivorship: a narrative review. Mhealth. 2018; 4:45. PMID: 30505843.
      View in: PubMed
    62. Lee MS, Hollenbeck BK, Oerline MK, Skolarus TA, Jacobs BL, Jen R, Luckenbaugh AN, Shahinian V, Borza T. Spillover Effects of the Hospital Readmissions Reduction Program on Radical Cystectomy Readmissions. Urol Pract. 2019 Nov; 6(6):350-356. PMID: 31709276.
      View in: PubMed
    63. Lee AJ, Liu X, Borza T, Qin Y, Li BY, Urish KL, Kirk PS, Gilbert S, Hollenbeck BK, Helm JE, Lavieri MS, Skolarus TA, Jacobs BL. Role of Post-Acute Care on Hospital Readmission After High-Risk Surgery. J Surg Res. 2019 02; 234:116-122. PMID: 30527462.
      View in: PubMed
    64. Skolarus TA, Caram ME, Chapman CH, Smith DC, Hollenbeck BK, Hawley S, Tsodikov A, Sales A, Wittmann D, Zaslavsky A. Castration remains despite decreasing definitive treatment of localized prostate cancer in the elderly: A case for de-implementation. Cancer. 2018 10 15; 124(20):3971-3974. PMID: 30192374.
      View in: PubMed
    65. Kirk PS, Borza T, Dupree JM, Wei JT, Ellimoottil C, Caram MEV, Burkhardt M, Heidelbaugh JJ, Hollenbeck BK, Skolarus TA. Potential Savings in Medicare Part D for Common Urological Conditions. Urol Pract. 2018 Sep; 5(5):351-359. PMID: 30555855.
      View in: PubMed
    66. Benson CR, Goldfarb R, Kirk P, Qin Y, Borza T, Skolarus TA, B Brandes S. Population Analysis of Male Urethral Stricture Management and Urethroplasty Success in the United States. Urology. 2019 01; 123:258-264. PMID: 30170091.
      View in: PubMed
    67. Meddings J, Skolarus TA, Fowler KE, Bernstein SJ, Dimick JB, Mann JD, Saint S. Michigan Appropriate Perioperative (MAP) criteria for urinary catheter use in common general and orthopaedic surgeries: results obtained using the RAND/UCLA Appropriateness Method. BMJ Qual Saf. 2019 01; 28(1):56-66. PMID: 30100564.
      View in: PubMed
    68. Modi PK, Kaufman SR, Borza T, Yan P, Miller DC, Skolarus TA, Hollingsworth JM, Norton EC, Shahinian VB, Hollenbeck BK. Variation in prostate cancer treatment and spending among Medicare shared savings program accountable care organizations. Cancer. 2018 08; 124(16):3364-3371. PMID: 29905943.
      View in: PubMed
    69. Urish KL, Qin Y, Li BY, Borza T, Sessine M, Kirk P, Hollenbeck BK, Helm JE, Lavieri MS, Skolarus TA, Jacobs BL. Predictors and Cost of Readmission in Total Knee Arthroplasty. J Arthroplasty. 2018 09; 33(9):2759-2763. PMID: 29753618.
      View in: PubMed
    70. Guo DP, Thomas IC, Mittakanti HR, Shelton JB, Makarov DV, Skolarus TA, Cooperberg MR, Sonn GA, Chung BI, Brooks JD, Leppert JT. The Research Implications of Prostate Specific Antigen Registry Errors: Data from the Veterans Health Administration. J Urol. 2018 09; 200(3):541-548. PMID: 29630980.
      View in: PubMed
    71. Luckenbaugh AN, Hollenbeck BK, Kaufman SR, Yan P, Herrel LA, Skolarus TA, Norton EC, Schroeck FR, Jacobs BL, Miller DC, Hollingsworth JM, Shahinian VB, Borza T. Impact of Accountable Care Organizations on Diagnostic Testing for Prostate Cancer. Urology. 2018 06; 116:68-75. PMID: 29630957.
      View in: PubMed
    72. Ginossar T, Heckman CJ, Cragun D, Quintiliani LM, Proctor EK, Chambers DA, Skolarus T, Brownson RC. Bridging the Chasm: Challenges, Opportunities, and Resources for Integrating a Dissemination and Implementation Science Curriculum into Medical Education. J Med Educ Curric Dev. 2018 Jan-Dec; 5:2382120518761875. PMID: 29707648.
      View in: PubMed
    73. Telem DA, Dimick J, Skolarus TA. Dissecting Surgeon Behavior: Leveraging the Theoretical Domains Framework to Facilitate Evidence-based Surgical Practice. Ann Surg. 2018 03; 267(3):432-434. PMID: 28902665.
      View in: PubMed
    74. Borza T, Oreline MK, Skolarus TA, Norton EC, Ryan AM, Ellimoottil C, Dimick JB, Shahinian VB, Hollenbeck BK. Association of the Hospital Readmissions Reduction Program With Surgical Readmissions. JAMA Surg. 2018 03 01; 153(3):243-250. PMID: 29167870.
      View in: PubMed
    75. Skolarus TA. Introduction to a Seminar on implementation and de-implementation to improve urologic cancer care. Urol Oncol. 2018 05; 36(5):244-245. PMID: 29455907.
      View in: PubMed
    76. Skolarus TA, Caram MV, Borza T. Editorial Comment. J Urol. 2018 05; 199(5):1172-1173. PMID: 29391136.
      View in: PubMed
    77. Dess RT, Devasia TP, Aghdam N, Jackson WC, Soni PD, Smith CP, Mitchell AL, Suy S, Hamstra DA, Jolly S, Nguyen PL, Feng FY, Schipper MJ, Skolarus TA, Miller DC, Wittmann DA, Collins SP, Spratt DE. Patient-Reported Sexual Aid Utilization and Efficacy After Radiation Therapy for Localized Prostate Cancer. Int J Radiat Oncol Biol Phys. 2018 06 01; 101(2):376-386. PMID: 29487023.
      View in: PubMed
    78. Kirk PS, Borza T, Shahinian VB, Caram MEV, Makarov DV, Shelton JB, Leppert JT, Blake RM, Davis JA, Hollenbeck BK, Sales A, Skolarus TA. The implications of baseline bone-health assessment at initiation of androgen-deprivation therapy for prostate cancer. BJU Int. 2018 04; 121(4):558-564. PMID: 29124881.
      View in: PubMed
    79. Borza T, Kaufman SR, Yan P, Herrel LA, Luckenbaugh AN, Miller DC, Skolarus TA, Jacobs BL, Hollingsworth JM, Norton EC, Shahinian VB, Hollenbeck BK. Early effect of Medicare Shared Savings Program accountable care organization participation on prostate cancer care. Cancer. 2018 02 01; 124(3):563-570. PMID: 29053177.
      View in: PubMed
    80. Wittmann D, Mehta A, Northouse L, Dunn R, Braun T, Duby A, An L, Arab L, Bangs R, Bober S, Brandon J, Coward M, Dunn M, Galbraith M, Garcia M, Giblin J, Glode M, Koontz B, Lowe A, Mitchell S, Mulhall J, Nelson C, Paich K, Saigal C, Skolarus T, Stanford J, Walsh T, Pollack CE. TrueNTH sexual recovery study protocol: a multi-institutional collaborative approach to developing and testing a web-based intervention for couples coping with the side-effects of prostate cancer treatment in a randomized controlled trial. BMC Cancer. 2017 Oct 02; 17(1):664. PMID: 28969611.
      View in: PubMed
    81. Fenstermaker M, Paknikar S, Rambhatla A, Ohl DA, Skolarus TA, Dupree JM. The State of Men's Health Services in the Veterans Health Administration. Curr Urol Rep. 2017 Sep 18; 18(11):88. PMID: 28921390.
      View in: PubMed
    82. Hollenbeck BK, Kaufman SR, Yan P, Herrel LA, Borza T, Schroeck FR, Jacobs BL, Skolarus TA, Shahinian VB. Urologist Practice Affiliation and Intensity-modulated Radiation Therapy for Prostate Cancer in the Elderly. Eur Urol. 2018 04; 73(4):491-498. PMID: 28823605.
      View in: PubMed
    83. Skolarus TA, Lehmann T, Tabak RG, Harris J, Lecy J, Sales AE. Assessing citation networks for dissemination and implementation research frameworks. Implement Sci. 2017 07 28; 12(1):97. PMID: 28754140.
      View in: PubMed
    84. Skolarus TA, Ragnoni JA, Garlinghouse C, Schafenacker A, Webster D, Hager P, Wittmann D, Northouse L. Multilingual Self-Management Resources for Prostate Cancer Survivors and Their Partners: Results of a Long-Term Academic-State Health Department Partnership to Promote Survivorship Care. Urology. 2017 Dec; 110:92-97. PMID: 28652166.
      View in: PubMed
    85. Caram MEV, Borza T, Min HS, Griggs JJ, Miller DC, Hollenbeck BK, Mukherjee B, Skolarus TA. Early National Dissemination of Abiraterone and Enzalutamide for Advanced Prostate Cancer in Medicare Part D. J Oncol Pract. 2017 08; 13(8):e694-e702. PMID: 28628393.
      View in: PubMed
    86. Skolarus TA, Wittmann D, Hawley ST. Enhancing prostate cancer survivorship care through self-management. Urol Oncol. 2017 09; 35(9):564-568. PMID: 28619632.
      View in: PubMed
    87. Skolarus TA, Metreger T, Hwang S, Kim HM, Grubb RL, Gingrich JR, Hawley ST. Optimizing veteran-centered prostate cancer survivorship care: study protocol for a randomized controlled trial. Trials. 2017 04 18; 18(1):181. PMID: 28420419.
      View in: PubMed
    88. Gilbert SM, Dunn RL, Miller DC, Montgomery JS, Skolarus TA, Weizer AZ, Wood DP, Hollenbeck BK. Functional Outcomes Following Nerve Sparing Prostatectomy Augmented with Seminal Vesicle Sparing Compared to Standard Nerve Sparing Prostatectomy: Results from a Randomized Controlled Trial. J Urol. 2017 09; 198(3):600-607. PMID: 28392393.
      View in: PubMed
    89. Borza T, Jacobs BL, Montgomery JS, Weizer AZ, Morgan TM, Hafez KS, Lee CT, Li BY, Min HS, He C, Gilbert SM, Helm JE, Lavieri MS, Hollenbeck BK, Skolarus TA. No Differences in Population-based Readmissions After Open and Robotic-assisted Radical Cystectomy: Implications for Post-discharge Care. Urology. 2017 06; 104:77-83. PMID: 28267606.
      View in: PubMed
    90. Jacobs BL, He C, Li BY, Helfand A, Krishnan N, Borza T, Ghaferi AA, Hollenbeck BK, Helm JE, Lavieri MS, Skolarus TA. Variation in readmission expenditures after high-risk surgery. J Surg Res. 2017 06 01; 213:60-68. PMID: 28601334.
      View in: PubMed
    91. Kirk PS, Govani S, Borza T, Hollenbeck BK, Davis J, Shumway D, Waljee AK, Skolarus TA. Implications of Prostate Cancer Treatment in Men With Inflammatory Bowel Disease. Urology. 2017 06; 104:131-136. PMID: 28163082.
      View in: PubMed
    92. Osawa T, Ambani SN, Skolarus TA, Morgan TM. Author Reply. Urology. 2017 04; 102:99. PMID: 28088433.
      View in: PubMed
    93. Borza T, Kaufman SR, Shahinian VB, Yan P, Miller DC, Skolarus TA, Hollenbeck BK. Sharp Decline In Prostate Cancer Treatment Among Men In The General Population, But Not Among Diagnosed Men. Health Aff (Millwood). 2017 01 01; 36(1):108-115. PMID: 28069853.
      View in: PubMed
    94. Osawa T, Ambani SN, Olugbade K, Skolarus TA, Weizer AZ, Montgomery JS, He C, Hafez KS, Hollenbeck BK, Lee CT, Montie JE, Palapattu GS, Morgan TM. Potential Implications of Shortening Length of Stay Following Radical Cystectomy in a Pre-ERAS Population. Urology. 2017 04; 102:92-99. PMID: 28013038.
      View in: PubMed
    95. Hollenbeck BK, Kaufman SR, Borza T, Yan P, Herrel LA, Miller DC, Luckenbaugh AN, Skolarus TA, Shahinian VB. Accountable care organizations and prostate cancer care. Urol Pract. 2017 Nov; 4(6):454-461. PMID: 29170755.
      View in: PubMed
    96. Mittakanti HR, Thomas IC, Shelton JB, Makarov DV, Skolarus TA, Cooperberg MR, Chung BI, Sonn GA, Brooks JD, Leppert JT. Accuracy of Prostate-Specific Antigen Values in Prostate Cancer Registries. J Clin Oncol. 2016 10 10; 34(29):3586-3587. PMID: 27458297.
      View in: PubMed
    97. Selove R, Birken SA, Skolarus TA, Hahn EE, Sales A, Proctor EK. Using Implementation Science to Examine the Impact of Cancer Survivorship Care Plans. J Clin Oncol. 2016 11 10; 34(32):3834-3837. PMID: 27621409.
      View in: PubMed
    98. Osawa T, Wittmann D, Jimbo M, Keller ET, Namiki S, Abe T, Shinohara N, Skolarus TA. Providing prostate cancer survivorship care in Japan: Implications from the USA care model. Int J Urol. 2016 11; 23(11):906-915. PMID: 27624609.
      View in: PubMed
    99. Hollenbeck BK, Bierlein MJ, Kaufman SR, Herrel L, Skolarus TA, Miller DC, Shahinian VB. Implications of evolving delivery system reforms for prostate cancer care. Am J Manag Care. 2016 Sep; 22(9):569-75. PMID: 27662220.
      View in: PubMed
    100. Helfand AM, Beach R, Hadj-Moussa M, Krishnan N, He C, Montgomery JS, Morgan TM, Weizer AZ, Hafez K, Lee CT, Stoffel JT, Skolarus TA. Treatment of ureteral anastomotic strictures with reimplantation and survival after cystectomy and urinary diversion. Urol Oncol. 2017 01; 35(1):33.e1-33.e9. PMID: 27595462.
      View in: PubMed
    101. Krishnan N, Li B, Jacobs BL, Ambani SN, Borza T, He C, Hollenbeck BK, Morgan T, Hafez KS, Weizer AZ, Montgomery JS, Lee CT, Lesse O, Lavieri MS, Helm JE, Skolarus TA. The Fate of Radical Cystectomy Patients after Hospital Discharge: Understanding the Black Box of the Pre-readmission Interval. Eur Urol Focus. 2018 09; 4(5):711-717. PMID: 28753778.
      View in: PubMed
    102. Herrel LA, Kaufman SR, Yan P, Miller DC, Schroeck FR, Skolarus TA, Shahinian VB, Hollenbeck BK. Health Care Integration and Quality among Men with Prostate Cancer. J Urol. 2017 01; 197(1):55-60. PMID: 27423758.
      View in: PubMed
    103. Skolarus TA, Sales AE. Using implementation science to improve urologic oncology care. Urol Oncol. 2016 09; 34(9):384-7. PMID: 27401405.
      View in: PubMed
    104. Bernat JK, Skolarus TA, Hawley ST, Haggstrom DA, Darwish-Yassine M, Wittmann DA. Negative information-seeking experiences of long-term prostate cancer survivors. J Cancer Surviv. 2016 12; 10(6):1089-1095. PMID: 27229868.
      View in: PubMed
    105. Kozminski MA, Tomlins S, Cole A, Singhal U, Lu L, Skolarus TA, Palapattu GS, Montgomery JS, Weizer AZ, Mehra R, Hollenbeck BK, Miller DC, He C, Feng FY, Morgan TM. Standardizing the definition of adverse pathology for lower risk men undergoing radical prostatectomy. Urol Oncol. 2016 09; 34(9):415.e1-6. PMID: 27140065.
      View in: PubMed
    106. Osawa T, Lee CT, Abe T, Takada N, Hafez KS, Montgomery JS, Weizer AZ, Hollenbeck BK, Skolarus TA, Murai S, Shinohara N, Morgan TM. A Multi-Center International Study Assessing the Impact of Differences in Baseline Characteristics and Perioperative Care Following Radical Cystectomy. Bladder Cancer. 2016 Apr 27; 2(2):251-261. PMID: 27376144.
      View in: PubMed
    107. Ellimoottil C, Skolarus T, Gettman M, Boxer R, Kutikov A, Lee BR, Shelton J, Morgan T. Telemedicine in Urology: State of the Art. Urology. 2016 08; 94:10-6. PMID: 27109596.
      View in: PubMed
    108. Wittmann D, Skolarus TA. Re: Neil E. Martin, Laura Massey, Caleb Stowell, et al. Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer. Eur Urol 2015;67:460-7. Eur Urol. 2016 06; 69(6):e125-6. PMID: 26873838.
      View in: PubMed
    109. Caram ME, Skolarus TA, Cooney KA. Limitations of Prostate-specific Antigen Testing After a Prostate Cancer Diagnosis. Eur Urol. 2016 08; 70(2):209-10. PMID: 26776937.
      View in: PubMed
    110. Mohler JL, Armstrong AJ, Bahnson RR, D'Amico AV, Davis BJ, Eastham JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, Hurwitz M, Kane CJ, Kawachi MH, Kuettel M, Lee RJ, Meeks JJ, Penson DF, Plimack ER, Pow-Sang JM, Raben D, Richey S, Roach M, Rosenfeld S, Schaeffer E, Skolarus TA, Small EJ, Sonpavde G, Srinivas S, Strope SA, Tward J, Shead DA, Freedman-Cass DA. Prostate Cancer, Version 1.2016. J Natl Compr Canc Netw. 2016 01; 14(1):19-30. PMID: 26733552.
      View in: PubMed
    111. Krishnan N, Liu X, Lavieri MS, Hu M, Helfand A, Li B, Helm JE, He C, Hollenbeck BK, Skolarus TA, Jacobs BL. A Model to Optimize Followup Care and Reduce Hospital Readmissions after Radical Cystectomy. J Urol. 2016 May; 195(5):1362-1367. PMID: 26682758.
      View in: PubMed
    112. Filson CP, Shelton JB, Tan HJ, Kwan L, Skolarus TA, Saigal CS, Litwin MS. Expectant management of veterans with early-stage prostate cancer. Cancer. 2016 Feb 15; 122(4):626-33. PMID: 26540451.
      View in: PubMed
    113. Paich K, Dunn R, Skolarus T, Montie J, Hollenbeck B, Palapattu G, Wood D, Mitchell S, Hola V, Erickson K, Shifferd J, Wittmann D. Preparing Patients and Partners for Recovery From the Side Effects of Prostate Cancer Surgery: A Group Approach. Urology. 2016 Feb; 88:36-42. PMID: 26541826.
      View in: PubMed
    114. Krishnan N, Fagerlin A, Skolarus TA. Rethinking Patient-Physician Communication of Biopsy Results--The Waiting Game. JAMA Oncol. 2015 Nov; 1(8):1025-6. PMID: 26270992.
      View in: PubMed
    115. Bernat JK, Wittman DA, Hawley ST, Hamstra DA, Helfand AM, Haggstrom DA, Darwish-Yassine M, Skolarus TA. Symptom burden and information needs in prostate cancer survivors: a case for tailored long-term survivorship care. BJU Int. 2016 09; 118(3):372-8. PMID: 26389529.
      View in: PubMed
    116. Evans JR, Zhao S, Daignault S, Sanda MG, Michalski J, Sandler HM, Kuban DA, Ciezki J, Kaplan ID, Zietman AL, Hembroff L, Feng FY, Suy S, Skolarus TA, McLaughlin PW, Wei JT, Dunn RL, Finkelstein SE, Mantz CA, Collins SP, Hamstra DA. Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapy. Radiother Oncol. 2015 Aug; 116(2):179-84. PMID: 26276528.
      View in: PubMed
    117. Chu S, Boxer R, Madison P, Kleinman L, Skolarus T, Altman L, Bennett C, Shelton J. Veterans Affairs Telemedicine: Bringing Urologic Care to Remote Clinics. Urology. 2015 Aug; 86(2):255-60. PMID: 26168998.
      View in: PubMed
    118. Chu S, Boxer R, Madison P, Kleinman L, Skolarus T, Altman L, Bennett C, Shelton J. Reply: To PMID 26168998. Urology. 2015 Aug; 86(2):260-1. PMID: 26169002.
      View in: PubMed
    119. Wittmann D, Skolarus TA, Montie JE. Are we targeting the right outcome for sexual health after prostate cancer treatment? Eur Urol. 2015 Oct; 68(4):550-1. PMID: 26058958.
      View in: PubMed
    120. Bourke L, Boorjian SA, Briganti A, Klotz L, Mucci L, Resnick MJ, Rosario DJ, Skolarus TA, Penson DF. Survivorship and improving quality of life in men with prostate cancer. Eur Urol. 2015 Sep; 68(3):374-83. PMID: 25941049.
      View in: PubMed
    121. Shelton JB, Ochotorena L, Bennett C, Shekelle P, Kwan L, Skolarus T, Goldzweig C. Reducing PSA-Based Prostate Cancer Screening in Men Aged?75 Years and Older with the Use of Highly Specific Computerized Clinical Decision Support. J Gen Intern Med. 2015 Aug; 30(8):1133-9. PMID: 25740462.
      View in: PubMed
    122. Skolarus TA. Editorial comment. Urology. 2015 Mar; 85(3):627-8. PMID: 25733276.
      View in: PubMed
    123. Skolarus TA, Hofer TP, Montgomery JS, Hafez K, Hollenbeck BK, Shelton JB, Antonio AL, Hawley ST, Sales AE. Urologist Workforce Variation Across the VHA. Fed Pract. 2015 Mar; 32(3):18-22. PMID: 30766048.
      View in: PubMed
    124. Skolarus TA, Dunn RL, Sanda MG, Chang P, Greenfield TK, Litwin MS, Wei JT. Minimally important difference for the Expanded Prostate Cancer Index Composite Short Form. Urology. 2015 Jan; 85(1):101-5. PMID: 25530370.
      View in: PubMed
    125. Skolarus TA, Jacobs BL, Schroeck FR, He C, Helfand AM, Helm J, Hu M, Lavieri M, Hollenbeck BK. Understanding hospital readmission intensity after radical cystectomy. J Urol. 2015 May; 193(5):1500-6. PMID: 25451833.
      View in: PubMed
    126. Skolarus TA, Caram MV, Shahinian VB. Androgen-deprivation-associated bone disease. Curr Opin Urol. 2014 Nov; 24(6):601-7. PMID: 25144145.
      View in: PubMed
    127. Wittmann D, Carolan M, Given B, Skolarus TA, Crossley H, An L, Palapattu G, Clark P, Montie JE. What couples say about their recovery of sexual intimacy after prostatectomy: toward the development of a conceptual model of couples' sexual recovery after surgery for prostate cancer. J Sex Med. 2015 Feb; 12(2):494-504. PMID: 25358901.
      View in: PubMed
    128. Schroeck FR, Kaufman SR, Jacobs BL, Skolarus TA, Zhang Y, Hollenbeck BK. Technology diffusion and prostate cancer quality of care. Urology. 2014 Nov; 84(5):1066-72. PMID: 25443905.
      View in: PubMed
    129. Skolarus TA, Hawley ST. Prostate cancer survivorship care in the Veterans Health Administration. Fed Pract. 2014 Aug; 31(8):10-17. PMID: 30369784.
      View in: PubMed
    130. Kozminski MA, Palapattu GS, Mehra R, Montgomery JS, Weizer AZ, Skolarus TA, Hollenbeck BK, Miller DC, He C, Tomlins S, Montie JE, Feng FY, Wood DP, Kunju LP, Morgan TM. Understanding the relationship between tumor size, gland size, and disease aggressiveness in men with prostate cancer. Urology. 2014 Aug; 84(2):373-8. PMID: 24958484.
      View in: PubMed
    131. Skolarus TA, Wolf AM, Erb NL, Brooks DD, Rivers BM, Underwood W, Salner AL, Zelefsky MJ, Aragon-Ching JB, Slovin SF, Wittmann DA, Hoyt MA, Sinibaldi VJ, Chodak G, Pratt-Chapman ML, Cowens-Alvarado RL. American Cancer Society prostate cancer survivorship care guidelines. CA Cancer J Clin. 2014 Jul-Aug; 64(4):225-49. PMID: 24916760.
      View in: PubMed
    132. Wittmann D, Carolan M, Given B, Skolarus TA, An L, Palapattu G, Montie JE. Exploring the role of the partner in couples' sexual recovery after surgery for prostate cancer. Support Care Cancer. 2014 Sep; 22(9):2509-15. PMID: 24728619.
      View in: PubMed
    133. Schroeck FR, Kaufman SR, Jacobs BL, Skolarus TA, Miller DC, Montgomery JS, Weizer AZ, Hollenbeck BK. Adherence to performance measures and outcomes among men treated for prostate cancer. J Urol. 2014 Sep; 192(3):743-8. PMID: 24681332.
      View in: PubMed
    134. Hu M, Jacobs BL, Montgomery JS, He C, Ye J, Zhang Y, Brathwaite J, Morgan TM, Hafez KS, Weizer AZ, Gilbert SM, Lee CT, Lavieri MS, Helm JE, Hollenbeck BK, Skolarus TA. Sharpening the focus on causes and timing of readmission after radical cystectomy for bladder cancer. Cancer. 2014 May 01; 120(9):1409-16. PMID: 24477968.
      View in: PubMed
    135. Shelton JB, Skolarus TA, Ordin D, Malin J, Antonio A, Ryoo J, Saigal CS. Validating electronic cancer quality measures at Veterans Health Administration. Am J Manag Care. 2014; 20(12):1041-7. PMID: 25526392.
      View in: PubMed
    136. Schroeck FR, Kaufman SR, Jacobs BL, Skolarus TA, Hollingsworth JM, Shahinian VB, Hollenbeck BK. Regional variation in quality of prostate cancer care. J Urol. 2014 Apr; 191(4):957-62. PMID: 24144685.
      View in: PubMed
    137. Skolarus TA, Chan S, Shelton JB, Antonio AL, Sales AE, Malin JL, Saigal CS. Quality of prostate cancer care among rural men in the Veterans Health Administration. Cancer. 2013 Oct 15; 119(20):3629-35. PMID: 23913676.
      View in: PubMed
    138. Jacobs BL, Zhang Y, Schroeck FR, Skolarus TA, Wei JT, Montie JE, Gilbert SM, Strope SA, Dunn RL, Miller DC, Hollenbeck BK. Use of advanced treatment technologies among men at low risk of dying from prostate cancer. JAMA. 2013 Jun 26; 309(24):2587-95. PMID: 23800935.
      View in: PubMed
    139. Schroeck FR, Kaufman SR, Jacobs BL, Skolarus TA, Miller DC, Weizer AZ, Montgomery JS, Wei JT, Shahinian VB, Hollenbeck BK. Technology diffusion and diagnostic testing for prostate cancer. J Urol. 2013 Nov; 190(5):1715-20. PMID: 23669564.
      View in: PubMed
    140. Schroeck FR, Skolarus TA. Editorial comment. Urology. 2013 Apr; 81(4):751. PMID: 23465169.
      View in: PubMed
    141. DeLancey JO, Wood DP, He C, Montgomery JS, Weizer AZ, Miller DC, Jacobs BL, Montie JE, Hollenbeck BK, Skolarus TA. Evidence of perineural invasion on prostate biopsy specimen and survival after radical prostatectomy. Urology. 2013 Feb; 81(2):354-7. PMID: 23374801.
      View in: PubMed
    142. Jacobs BL, Zhang Y, Skolarus TA, Wei JT, Montie JE, Schroeck FR, Hollenbeck BK. Managed care and the diffusion of intensity-modulated radiotherapy for prostate cancer. Urology. 2012 Dec; 80(6):1236-42. PMID: 23206767.
      View in: PubMed
    143. Jacobs BL, Zhang Y, Tan HJ, Ye Z, Skolarus TA, Hollenbeck BK. Hospitalization trends after prostate and bladder surgery: implications of potential payment reforms. J Urol. 2013 Jan; 189(1):59-65. PMID: 23164391.
      View in: PubMed
    144. Jacobs BL, Zhang Y, Skolarus TA, Wei JT, Montie JE, Schroeck FR, Hollenbeck BK. Certificate of need legislation and the dissemination of robotic surgery for prostate cancer. J Urol. 2013 Jan; 189(1):80-5. PMID: 23164388.
      View in: PubMed
    145. Jacobs BL, Zhang Y, Skolarus TA, Wei JT, Montie JE, Schroeck FR, Hollenbeck BK. Certificate of need regulations and the diffusion of intensity-modulated radiotherapy. Urology. 2012 Nov; 80(5):1015-20. PMID: 22999447.
      View in: PubMed
    146. Skolarus TA, Holmes-Rovner M, Hawley ST, Dunn RL, Barr KL, Willard NR, Wei JT, Piette JD, An LC. Monitoring quality of life among prostate cancer survivors: the feasibility of automated telephone assessment. Urology. 2012 Nov; 80(5):1021-6. PMID: 22990056.
      View in: PubMed
    147. Jacobs BL, Zhang Y, Skolarus TA, Wei JT, Montie JE, Miller DC, Hollenbeck BK. Comparative effectiveness of external-beam radiation approaches for prostate cancer. Eur Urol. 2014 Jan; 65(1):162-8. PMID: 22790288.
      View in: PubMed
    148. Jacobs BL, Zhang Y, Skolarus TA, Hollenbeck BK. Growth of high-cost intensity-modulated radiotherapy for prostate cancer raises concerns about overuse. Health Aff (Millwood). 2012 Apr; 31(4):750-9. PMID: 22492892.
      View in: PubMed
    149. Hollingsworth JM, Zhang YS, Miller DC, Skolarus TA, Wood DP, Lee CT, Montie JE, Hollenbeck BK. Identifying better practices for early-stage bladder cancer. Med Care. 2011 Dec; 49(12):1112-7. PMID: 21979371.
      View in: PubMed
    150. Jacobs BL, Montgomery JS, Zhang Y, Skolarus TA, Weizer AZ, Hollenbeck BK. Disparities in bladder cancer. Urol Oncol. 2012 Jan-Feb; 30(1):81-8. PMID: 22127016.
      View in: PubMed
    151. Skolarus TA, Ye Z, Montgomery JS, Weizer AZ, Hafez KS, Lee CT, Miller DC, Wood DP, Montie JE, Hollenbeck BK. Use of restaging bladder tumor resection for bladder cancer among Medicare beneficiaries. Urology. 2011 Dec; 78(6):1345-9. PMID: 21996111.
      View in: PubMed
    152. Skolarus TA, Zhang Y, Hollenbeck BK. Understanding fragmentation of prostate cancer survivorship care: implications for cost and quality. Cancer. 2012 Jun 01; 118(11):2837-45. PMID: 22370955.
      View in: PubMed
    153. Skolarus TA, Holmes-Rovner M, Northouse LL, Fagerlin A, Garlinghouse C, Demers RY, Rovner DR, Darwish-Yassine M, Wei JT. Primary care perspectives on prostate cancer survivorship: implications for improving quality of care. Urol Oncol. 2013 Aug; 31(6):727-32. PMID: 21775171.
      View in: PubMed
    154. Skolarus TA, Holmes-Rovner M, Northouse LL, Fagerlin A, Garlinghouse C, Demers RY, Rovner DR, Darwish-Yassine M, Wei JT. Primary care perspectives on prostate cancer screening. Nurse Pract. 2011 Jun; 36(6):39-44. PMID: 21572298.
      View in: PubMed
    155. Skolarus TA, Weizer AZ, Hedgepeth RC, He C, Wood DP, Hollenbeck BK. Understanding early functional recovery after robotic prostatectomy. Surg Innov. 2012 Mar; 19(1):5-10. PMID: 21521701.
      View in: PubMed
    156. Jacobs BL, Skolarus TA, Hollenbeck BK. Editorial comment. Urology. 2011 Feb; 77(2):279. PMID: 21295244.
      View in: PubMed
    157. Zhang Y, Skolarus TA, Miller DC, Wei JT, Hollenbeck BK. Understanding prostate cancer spending growth among Medicare beneficiaries. Urology. 2011 Feb; 77(2):326-31. PMID: 21168902.
      View in: PubMed
    158. Hedgepeth RC, Zhang Y, Skolarus TA, Hollenbeck BK. Variation in use of lymph node dissection during radical cystectomy for bladder cancer. Urology. 2011 Feb; 77(2):385-90. PMID: 21145577.
      View in: PubMed
    159. Hollenbeck BK, Dunn RL, Ye Z, Hollingsworth JM, Skolarus TA, Kim SP, Montie JE, Lee CT, Wood DP, Miller DC. Delays in diagnosis and bladder cancer mortality. Cancer. 2010 Nov 15; 116(22):5235-42. PMID: 20665490.
      View in: PubMed
    160. Filson CP, Hollingsworth JM, Skolarus TA, Clemens JQ, Hollenbeck BK. Health care reform in 2010: transforming the delivery system to improve quality of care. World J Urol. 2011 Feb; 29(1):85-90. PMID: 21046111.
      View in: PubMed
    161. Skolarus TA, Miller DC, Zhang Y, Hollingsworth JM, Hollenbeck BK. The delivery of prostate cancer care in the United States: implications for delivery system reform. J Urol. 2010 Dec; 184(6):2279-84. PMID: 20952017.
      View in: PubMed
    162. Skolarus TA, Hollenbeck BK, Zhang S. Editorial comment. Urology. 2010 Sep; 76(3):707-8; discussion 708-9. PMID: 20832634.
      View in: PubMed
    163. Skolarus TA, Hedgepeth RC, Zhang Y, Weizer AZ, Montgomery JS, Miller DC, Wood DP, Hollenbeck BK. Does robotic technology mitigate the challenges of large prostate size? Urology. 2010 Nov; 76(5):1117-21. PMID: 20708781.
      View in: PubMed
    164. Skolarus TA, Zhang Y, Hollenbeck BK. Robotic surgery in urologic oncology: gathering the evidence. Expert Rev Pharmacoecon Outcomes Res. 2010 Aug; 10(4):421-32. PMID: 20715919.
      View in: PubMed
    165. Skolarus TA, Zhang Y, Miller DC, Wei JT, Hollenbeck BK. The economic burden of prostate cancer survivorship care. J Urol. 2010 Aug; 184(2):532-8. PMID: 20620413.
      View in: PubMed
    166. Skolarus TA, Zhang S, Hollenbeck BK. Improving urologic cancer care. Urol Oncol. 2010 Jul-Aug; 28(4):347-9. PMID: 20451419.
      View in: PubMed
    167. Skolarus TA, Ye Z, Zhang S, Hollenbeck BK. Regional differences in early stage bladder cancer care and outcomes. Urology. 2010 Aug; 76(2):391-6. PMID: 20394976.
      View in: PubMed
    168. Katz MD, Serrano MF, Grubb RL, Skolarus TA, Gao F, Humphrey PA, Kibel AS. Percent microscopic tumor necrosis and survival after curative surgery for renal cell carcinoma. J Urol. 2010 Mar; 183(3):909-14. PMID: 20083280.
      View in: PubMed
    169. Skolarus TA, Serrano MF, Grubb RL, Katz MD, Bullock TL, Gao F, Humphrey PA, Kibel AS. Effect of reclassification on the incidence of benign and malignant renal tumors. J Urol. 2010 Feb; 183(2):455-8. PMID: 20006852.
      View in: PubMed
    170. Katz MD, Serrano MF, Humphrey PA, Grubb RL, Skolarus TA, Gao F, Kibel AS. The role of lymphovascular space invasion in renal cell carcinoma as a prognostic marker of survival after curative resection. Urol Oncol. 2011 Nov-Dec; 29(6):738-44. PMID: 19914106.
      View in: PubMed
    171. Skolarus TA, Lee EW, Virgo KS, Katz MD, Hudson MA, Kibel AS, Grubb RL. Intravesical bacille Calmette-Guérin therapy for non-muscle-invasive bladder cancer: effects of concurrent statin therapy. J Am Coll Surg. 2009 Aug; 209(2):248-53. PMID: 19632602.
      View in: PubMed
    172. Skolarus TA, Wei JT. Measurement of benign prostatic hyperplasia treatment effects on male sexual function. Int J Impot Res. 2009 Sep-Oct; 21(5):267-74. PMID: 19536125.
      View in: PubMed
    173. Anast JW, Skolarus TA, Yan Y, Klutke CG. Transobturator sling with intraoperative cough test is effective for patients with low valsalva leak point pressure. Can J Urol. 2008 Aug; 15(4):4153-7. PMID: 18706141.
      View in: PubMed
    174. Skolarus TA, Bhayani SB, Chiang HC, Brandes SB, Kibel AS, Landman J, Figenshau RS. Laparoscopic retroperitoneal lymph node dissection for low-stage testicular cancer. J Endourol. 2008 Jul; 22(7):1485-9. PMID: 18613781.
      View in: PubMed
    175. Skolarus TA, Serrano MF, Berger DA, Bullock TL, Yan Y, Humphrey PA, Kibel AS. The distribution of histological subtypes of renal tumors by decade of life using the 2004 WHO classification. J Urol. 2008 Feb; 179(2):439-43; discussion 443-4. PMID: 18076932.
      View in: PubMed
    176. Skolarus TA, Wolin KY, Grubb RL. The effect of body mass index on PSA levels and the development, screening and treatment of prostate cancer. Nat Clin Pract Urol. 2007 Nov; 4(11):605-14. PMID: 17982437.
      View in: PubMed
    Skolarus's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _